Current report
according to ASF Regulation no. 5/2018
|
Report date:
|
16.02.2021
|
|
Name of issuer:
|
Farmaceutica REMEDIA S.A.
|
|
Registered office:
|
Deva, no. 2, Nicolae Balcescu Blvd
|
|
Tel/ fax no:
|
+40 254 22 32 60 / +40 254 22 61 97
|
|
ORC no:
|
2115198
|
|
Trade Registry no:
|
J20 / 700 / 1991
|
|
Subscribed and paid-in capital:
|
LEI 10.608.980
|
|
Regulated market:
|
Bucharest Stock Exchange, Standard Category
|
Important events to report:
RELEASE
The Board of Admnistrators of Farmaceutica REMEDIA S.A. informs that the Preliminary Annual Report for 2020 - the full version - is available on its own website http://www.remedia.ro/en/investors-2-2/company-financials/ and and in the link from the IRIS platform, below.
During 01.01.2020 – 31.12.2020, the commercial company Farmaceutica REMEDIA S.A. recorded the following consolidated financial results:
|
Crt.
No.
|
Indicator
|
Realisations Jan-Sept 2020 (Lei)
|
Realisations Jan-Sept 2019 (Lei)
|
Evlution 2020/2019 (%)
|
|
1.
|
Net sales of goods *
|
438.804.422
|
442.937.642
|
-0,9
|
|
2.
|
Other operating revenues
|
43.999.086
|
9.189.616
|
378,8
|
|
3.
|
Total operating income
|
482.803.508
|
452.127.257
|
6,8
|
|
4.
|
Total operational costs *
|
439.938.344
|
448.323.839
|
-1,9
|
|
5.
|
Operating result
|
42.865.165
|
3.803.418
|
1.027
|
|
6.
|
Financial result
|
-93.967
|
-680.485
|
113,8
|
|
7.
|
Gross result
|
42.771.198
|
3.122.933
|
1.269,6
|
* Including trade discounts granted/received
The economic - financial indicators on 31.12.2020 are presented in the following table:
|
LIQUIDITY AND WORKING CAPITAL
|
Farmaceutica REMEDIA SA
|
Farmaceutica REMEDIA Distribution & Logistics SRL
|
|
Current liquidity (Current assets / Current debts)
|
9,26
|
1,03
|
|
Current assets
|
29.376.485
|
174.917.898
|
|
Current debts
|
3.172.399
|
169.694.824
|
|
Degree of indebtedness (Borrowed capital / Equity x 100)
|
0%
|
0%
|
|
Borrowed capital
|
0
|
0
|
|
Equity
|
73.672.543
|
5.946.114
|
|
Turnover speed for client debit items (Average customer balance /turnover *365)
|
52 zile
|
111 zile
|
|
Average customer balance
|
9.172.151
|
125.432.624
|
|
Net turnover
|
63.833.250
|
411.345.503
|
|
Turnover speed of stocks (average stock/ net COGS)*365
|
55 zile
|
39 zile
|
|
Average stock
|
7.620.605
|
41.192.245
|
|
COGS net
|
50.039.120
|
381.371.761
|
*including financial leasing
Notes:
1) Current liquidity – the indicator level reflects a good payment capacity, therefore a reduced risk for creditors, certifying that the company is able to cover their short-term debts based on receivables and cash availabilities.
2) Degree of indebtedness expresses the effectiveness of credit risk management, indicating potential financing, liquidity problems, with influences in honouring the assumed commitments. In the case of both companies there is no risk. In the calculation of this indicator, the borrowed capital comprises both bank credits, and financial leasing debts.
3) Turnover speed for client debit items expresses company effectiveness in collecting its receivables, respectively the number of days until the date on which debtors pay their debts to the company. Considering the dynamics of sales and the specific of collecting receivables in the distribution of drugs, we believe that the value of the indicator is normal for the both companies, under the circumstances.
4) The value of the No. of storage Days indicator can be considered as falling within the specifics of the activity.
Chairman of the Board of Administrators,
„TARUS” – Valentin Norbert TARUS e.U.